8 completed, 1 not yet recruiting. 9 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 8, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow CoQ10: new trials by email Literature Review of CoQ10 trials Research Report on CoQ10
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity Vitamin C, Coenzyme Q 10 - Nephrotoxicity | Phase 2 / Phase 3 | Not yet recruiting | Ain Shams University | 75 | 2026-04-20 | 2026-03-17 |
| Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease CoQ10, Nicotinamide riboside, Placebo - Chronic Kidney Disease, Sarcopenia | Phase 2 | Completed | University of Washington | 26 | 2018-11-14 | 2023-01-10 |
| CoQ10 and D-ribose in Patients With Diastolic Heart Failure CoQ10, D-Ribose Oral Powder, Placebo pills - Heart Failure, Diastolic | Phase 2 | Completed | University of Kansas Medical Center | 216 | 2018-02-05 | 2022-03-18 |
| Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest Ubiquinol, Ensure - Cardiac Arrest | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 48 | 2016-03-01 | 2021-02-15 |
| Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL) CoQ10 - Huntington's Disease | Phase 2 | Completed | Johns Hopkins University | 90 | 2010-02-01 | 2017-09-25 |
| Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Coenzyme Q10 - Charcot Marie Tooth Disease | Phase 1 / Phase 2 | Completed | Memorial Medical Center | 23 | 2007-09-01 | 2013-07-15 |
| Clinical Trial of High Dose CoQ10 in ALS coenzyme Q10, Placebo - Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease | Phase 2 | Completed | Columbia University | 185 | 2005-04-01 | 2024-05-07 |
| Effects of Coenzyme Q10 in PSP and CBD CoQ10 - Progressive Supranuclear Palsy, Neurological Disorders | Phase 2 / Phase 3 | Completed | Lahey Clinic | 2004-01-01 | 2018-06-15 | |
| NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 CoQ10, GPI 1485 - Parkinson Disease | Phase 2 | Completed | University of Rochester | 195 | 2004-01-01 | 2012-11-02 |
Amyotrophic Lateral Sclerosis (1) · Charcot-Marie-Tooth Disease (1) · Fatigue (1) · Frailty (1) · Heart Arrest (1) · Heart Failure, Diastolic (1) · Huntington Disease (1) · Mitochondrial Diseases (1) · Neoplasms (1) · Nervous System Diseases (1) · Parkinson Disease (1) · Renal Insufficiency, Chronic (1) · Sarcopenia (1) · Supranuclear Palsy, Progressive (1)
Ain Shams University (1) · Beth Israel Deaconess Medical Center (1) · Columbia University (1) · Johns Hopkins University (1) · Lahey Clinic (1) · Memorial Medical Center (1) · University of Kansas Medical Center (1) · University of Rochester (1) · University of Washington (1)
United States (8) · Egypt (1)
Baback Roshanravan, MD (1) · Barbara Tilley, Ph.D. (1) · Bryan Kestenbaum, MD (1) · Christopher A Ross, MD, PhD (1) · Diana Apetauerova, MD (1) · Hiroshi Mitsumoto (1) · J. L. P. Thompson, Ph.D. (1) · Janet Pierce, PhD (1) · Karl Kieburtz, MD, MPH (1) · Kevin M Biglan, MD, MPH (1) · Michael W Donnino, MD (1) · Nagwa A Sabri, PHD (1) · Petra Kaufmann, MD (1) · Sharon Plank, MD (1)
PMID 19743457, PMID 24711047, PMID 29606104, PMID 35644694, PMID 37159264, PMID 39847432
R01AG054486 (1), R01DK101509 (1), R01NS048125 (1), U01NS043128 (1)